The fluorescent carbon quantum dots (CQDs) represent an emerging subset of carbonaceous nanomaterials, recently becoming a powerful tool for biosensing, bioimaging, and drug and gene delivery. In general, carbon dots are defined as zero-dimensional (0D), spherical-like nanoparticles with <10 nm in size. Their unique chemical, optical, and electronic properties make CQDs versatile materials for a wide spectrum of applications, mainly for the sensing and biomedical purposes. Due to their good biocompatibility, water solubility, and relatively facile modification, these novel materials have attracted tremendous interest in recent years, which is especially important for nanotechnology and nanoscience expertise. The preparation of the biomass-derived CQDs has attracted growing interest recently due to their low-cost, renewable, and green biomass resources, presenting also the variability of possible modification for the enhancement of CQDs’ properties. This review is primarily focused on the recent developments in carbon dots and their application in the sensing of different chemical species within the last five years. Furthermore, special emphasis has been made regarding the green approaches for obtaining CQDs and nanomaterial characterization toward better understanding the mechanisms of photoluminescent behavior and sensing performance. In addition, some of the challenges and future outlooks in CQDs research have been briefly outlined.

Carbon quantum dots (CQDs) have recently emerged as innovative theranostic nanomaterials, enabling fast and effective diagnosis and treatment. In this study, a facile hydrothermal approach for N-doped biomass-derived CQDs preparation from Citrus clementina peel and amino acids glycine (Gly) and arginine (Arg) has been presented. The gradual increase in the N-dopant (amino acids) nitrogen content increased the quantum yield of synthesized CQDs. The prepared CQDs exhibited good biocompatibility, stability in aqueous, and high ionic strength media, similar optical properties, while differences were observed regarding the structural and chemical diversity, and biological and antioxidant activity. The antiproliferative effect of CQD@Gly against pancreatic cancer cell lines (CFPAC-1) was observed. At the same time, CQD@Arg has demonstrated the highest quantum yield and antioxidant activity by DPPH scavenging radical method of 81.39 ± 0.39% and has been further used for the ion sensing and cellular imaging of cancer cells. The obtained results have demonstrated selective response toward Fe³⁺ detection, with linear response ranging from 7.0 µmol dm⁻³ to 50.0 µmol dm⁻³ with R² = 0.9931 and limit of detection (LOD) of 4.57 ± 0.27 µmol dm⁻³. This research could be a good example of sustainable biomass waste utilization with potential for biomedical analysis and ion sensing applications.

This work reports the preparation of amino acid-functionalized CQDs from citric acid by facile hydrothermal synthesis. The prepared N-doped CQDs exhibited excellent optical, physical, and chemical properties, and the differences were observed among the six different amino acids used as nitrogen dopants (Leu, Trp, Lys, Arg, Ala, His). Compared to the blank sample (without the addition of amino acids), N-doped CQDs have shown significantly higher quantum yield, also demonstrating the potential in metal ion sensing. The highest quantum yield of 36.45%, with a peak excitation/emission of 340/406 nm, was achieved using citric acid and amino acid Leu (CQD@Leu), treated at temperature of 180 °C during 9 h. The prepared samples were investigated toward metal ion selectivity (Ca²⁺, Cu²⁺, Fe³⁺, K⁺, Hg²⁺, Mg²⁺, Al³⁺, Mn²⁺, and Na⁺), and the CQD@Leu showed a selective and sensitive response upon the addition of Fe³⁺ ions. Therefore, CQD@Leu was selected for further investigation in Fe³⁺ detection in the model system and real well water samples. A developed model was described by a logistic function with a good coefficient of determination of R² = 0.9982, while the linear range was determined in the concentration range from 0.3 mol dm⁻³ to 30 mol dm⁻³, with a determined limit of detection of LOD = 1.77 ± 0.01 mol dm⁻³ and limit of quantification of LOQ = 5.89 ± 0.04 mol dm⁻³. Furthermore, the results of the in vitro cytotoxicity test (MTT) with normal and tumor cell lines (MRC-5, HeLa, NCI-H358, and CaCo-2) clearly demonstrate the excellent biocompatibility of CQD@Leu.

Sr₃Fe₂WO₉ and Ba₃Fe₂WO₉ triple perovskites have been prepared in nanocrystalline form using a modified sol–gel route with citric acid as a chelating agent. These materials have been studied by X-ray powder diffraction (PXRD), energy-dispersive X-ray (EDX) spectroscopy, transmission electron microscopy (TEM), scanning electron microscopy (SEM), and unpolarized Raman spectroscopy, while their magnetic properties have been determined using SQUID measurements. At room temperature, the crystal structure of 6H-perovskite Ba₃Fe₂WO₉ is hexagonal, space group P6₃/mmc, with a = 5.7577(2) and c = 14.1095(5) Å, whereas Sr₃Fe₂WO₉ presents a tetragonal lattice, space group I4/m, with a = 5.5803(1) and c = 7.8745(3) Å. Both compounds are nanocrystalline with average crystallite sizes of 25.6(1) nm for Ba₃Fe₂WO₉ and 35.9(1) nm for Sr₃Fe₂WO₉ with moderate microstrain. They exhibit a disordered perovskite structure, in which Fe³⁺ and W⁶⁺ cations distribute randomly at the B-sites of the perovskite lattice: Sr₂[Fe_0.72W_0.28]^2a[Fe_0.61W_0.39]^2bO₆ and Ba₆[Fe_1.71W_0.29]^2a[Fe_2.29W_1.71]^4fO₁₈. The detected hysteresis loops with non-zero remanent magnetization and a rather large coercive field reveal ferrimagnetic ordering with ordering temperatures of 373 K for Sr₃Fe₂WO₉ and 330 K for Ba₃Fe₂WO₉. Magnetic measurements show the onset of ferrimagnetic ordering at relatively high temperatures of 717 and 711 K for the Sr and Ba compounds, respectively; however the magnetization isotherms at 2 K exhibit, for H = 50 kOe, maximum magnetization values close to 0.8 μ_B (f.u.)⁻¹ and 0.35 μ_B (f.u.)⁻¹ for Sr and Ba compounds, respectively, although full saturation is not reached.

The search for an efficient drug or inhibitor in the formation process of kidney stones has been a promising research topic towards reducing the risks of the formation of disease. However, several challenges have been faced in investigating the most common constituents of kidney stones, calcium oxalate and its hydrate forms (COM, COD and COT). This study focuses on the preparation and structural characterization (TG, XRD, FTIR, SEM) of calcium oxalate hydrates in the presence of gallic acid (GA) and by varying operating parameters such as temperature (25 °C, 36.5 °C and 48 °C), pH (5.6, 6.5 and 7.5) and amount of added GA (ranging from 100 mg to 1000 mg). Response surface methodology was applied in order to evaluate the effects of operating parameters in the formation of COM and COD, and for the process optimization towards maximizing their content in samples. The results indicated that GA inhibited the formation of COM (0–100%) and promoted the formation of COD (0 ≤ 99%), while a medium pH and the amount of added GA showed a significant effect in the process of COD formation. In order to investigate the interactions established in the formation process and the possible adsorption between GA and the formed crystals, electrochemical measurements were performed.